OBJECTIVES: In @entity309 ( @entity309 ) and @entity571 ( @entity571 ) forefoot involvement causes disability and @entity7529 . Our objective was to evaluate, in @entity309 and @entity571 @entity1 , the efficacy of two protocols combining insoles in polypropylene terephtalate ( @entity3445 ) and custom @entity1346 orthoses for toes on disability and @entity7529 . METHODS: Twenty-four @entity1 (13 with @entity571 , 11 with @entity309 ) with @entity7529 were treated with two protocols: group A (protocol A) wore @entity3445 insoles (T1) for 30 days and for another 30 days @entity1346 orthosis for toes were added (T2). Group B (protocol B) wore @entity3445 insoles and @entity1346 orthosis (T1) for 30 days and in the following 30 days only insoles (T2). At T0, T1 and T2, @entity158 , disability and function (Foot Function Index - FFI), pressure (KPA) and plantar contact areas (cm2) (baropodometer), and gait spatial-temporal parameters (GAITRite  ) were assessed. RESULTS: At T0 versus T2, both protocols reduced @entity158 , -disability and -functional limitation (p<0.05), with better results of protocol A than protocol B (p<0.05) for @entity158 and -disability. Both protocols reduced baropodometer foot plantar pressures (p<0.001), with better results for protocol A for right foot pressures (p<0.05) and increased foot contact areas (p<0.05), with no difference between them (p=NS). Gait parameters were not significantly changed by both protocols (p=NS). CONCLUSIONS: In @entity1 with @entity309 and @entity571 with @entity7529 , the synergic action of @entity1346 toe orthosis and @entity3445 insoles improves FFI, @entity551 and increases foot plantar contact areas. Protocol A, using firstly insoles and then adding @entity1346 toe orthoses, is the more efficacious.

A comparison of two podiatric protocols for @entity7529 in @entity1 with @entity309 and XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity571 :: ('MESH:D010003', 'Disease') :: ['osteoarthritis', 'OA'] @entity3445 :: ('CHEBI:61453', 'Chemical') :: ['PPT'] @entity7529 :: ('MESH:D037061', 'Disease') :: ['metatarsalgia'] @entity1346 :: ('MESH:D012828', 'Chemical') :: ['silicone'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'FFI-pain'] @entity551 :: ('MESH:D007022', 'Disease') :: ['reduces foot plantar pressures'] @entity309 :: ('MESH:D001172', 'Disease') :: ['rheumatoid arthritis', 'RA']
@entity571 :: (MESH:D010003,Disease) :: ['osteoarthritis']
